These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 10918230)
1. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230 [TBL] [Abstract][Full Text] [Related]
2. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. Keleti J; Quezado MM; Abaza MM; Raffeld M; Tsokos M Am J Pathol; 1996 Jul; 149(1):143-51. PubMed ID: 8686737 [TBL] [Abstract][Full Text] [Related]
4. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Takahashi Y; Oda Y; Kawaguchi K; Tamiya S; Yamamoto H; Suita S; Tsuneyoshi M Mod Pathol; 2004 Jun; 17(6):660-9. PubMed ID: 15098008 [TBL] [Abstract][Full Text] [Related]
5. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas. Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877 [TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
7. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. Waber PG; Chen J; Nisen PD Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417 [TBL] [Abstract][Full Text] [Related]
8. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888 [TBL] [Abstract][Full Text] [Related]
9. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044 [TBL] [Abstract][Full Text] [Related]
10. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. Habuchi T; Kinoshita H; Yamada H; Kakehi Y; Ogawa O; Wu WJ; Takahashi R; Sugiyama T; Yoshida O J Natl Cancer Inst; 1994 Sep; 86(17):1331-5. PubMed ID: 8064891 [TBL] [Abstract][Full Text] [Related]
11. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Günther T; Schneider-Stock R; Häckel C; Kasper HU; Pross M; Hackelsberger A; Lippert H; Roessner A Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665 [TBL] [Abstract][Full Text] [Related]
12. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Zhou M; Yeager AM; Smith SD; Findley HW Blood; 1995 Mar; 85(6):1608-14. PubMed ID: 7888679 [TBL] [Abstract][Full Text] [Related]
14. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours. Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619 [TBL] [Abstract][Full Text] [Related]